CL
AMPH icon

CIM LLC’s Amphastar Pharmaceuticals AMPH Stock Holding History

CIM LLC’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,342
Closed -$304K – 170
2025
Q4 		$304K Sell
11,342
-286
-2% -$7.37K 0.04% 150
2025
Q3 		$310K Buy
11,628
+199
+2% +$5.14K 0.04% 148
2025
Q2 		$262K Buy
11,429
+1,541
+16% +$38.2K 0.04% 154
2025
Q1 		$287K Sell
9,888
-190
-2% -$6.07K 0.04% 133
2024
Q4 		$374K Buy
10,078
+126
+1% +$5.76K 0.05% 131
2024
Q3 		$483K Sell
9,952
-64
-0.6% -$2.81K 0.07% 118
2024
Q2 		$455K Buy
10,016
+701
+8% +$29K 0.07% 112
2024
Q1 		$409K Buy
9,315
+70
+0.8% +$3.62K 0.06% 115
2023
Q4 		$480K Buy
9,245
+505
+6% +$26.5K 0.07% 107
2023
Q3 		$402K Sell
8,740
-416
-5% -$22.7K 0.08% 107
2023
Q2 		$526K Buy
9,156
+2,804
+44% +$124K 0.1% 100
2023
Q1 		$238K Sell
6,352
-149
-2% -$4.88K 0.05% 136
2022
Q4 		$203K Sell
6,501
-151
-2% -$4.38K 0.04% 145
2022
Q3 		$208K Buy
+6,652
New +$217K 0.04% 142

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

CIM LLC's AMPH Position: Q1 2026 in Review

CIM LLC sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 11,342 shares — an estimated $304K sold.

CIM LLC first reported a position in AMPH in Q3 2022 and held it in 14 quarters. The position peaked at $526K in Q2 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • CIM LLC reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • CIM LLC sold 11,342 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $304K.
  • CIM LLC first reported a position in Amphastar Pharmaceuticals in Q3 2022 and held it in 14 quarters.
  • CIM LLC's Amphastar Pharmaceuticals position peaked at $526K in Q2 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on CIM LLC's 13F filing for Q1 2026, filed 18 May 2026.